Prostate Cancer Vaccine Contains Genetically Modified DNA


Monday, 16 April 2012 09:10


Share

‘The treatment, which uses viruses carrying human DNA to direct the body’s natural defences against cancer cells, is the first prostate cancer vaccine ever to reach late stage “phase three” trials in Europe.

No vaccines have yet been approved in Britain to treat any type of cancer, and scientists believe it could not only double the survival rate of prostate cancer sufferers but give way to a new range of similar treatments for other tumour types.’

Read more: Prostate Cancer Vaccine Contains Genetically Modified DNA

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes